{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig7f3jux7rohdr6rjsakyef3gklkbxnvfi37eukbvkvzeuwhjgive",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mp73elr647q2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifmg4fdmak3l5mxysjv2bgteqp2quuqzlr6yzns2a4wjb76nvs2qi"
    },
    "mimeType": "image/jpeg",
    "size": 27785
  },
  "path": "/2026/06/26/biotech-news-embryo-editing-advances-reignite-ethics-debates/?utm_campaign=rss",
  "publishedAt": "2026-06-26T13:40:44.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Cassidy targets 340B, Eli Lilly's mysterious retatrutide patient, and more biotech news from The Readout",
  "title": "STAT+: Embryo editing advances reignite ethical debates",
  "updatedAt": "2026-06-26T13:40:48.000Z"
}